Allergy Diagnostics and Therapeutics Market is experiencing significant growth as the global burden of allergic diseases continues to rise. Increasing cases of allergic rhinitis, asthma, food allergies, atopic dermatitis, and drug allergies are driving the demand for accurate diagnostic solutions and effective treatment options. Factors such as rapid urbanization, environmental pollution,...

PCR Based Transplant Diagnostics Market Overview According to MarketGenics, the global PCR Based Transplant Diagnostics Market is projected to grow from USD 1.9 billion in 2025 to approximately USD 1.1 billion by 2035, registering a CAGR of 7.8% during the forecast period. The market is expanding steadily due to the increasing number of organ and stem cell transplant procedures, rising...

The global Cancer Diagnostics Market is expanding as healthcare providers increasingly invest in liquid biopsy, next-generation sequencing, molecular assays, digital pathology, and early-detection platforms to improve accuracy and support precision oncology. According to Business Market Insights, the Cancer Diagnostics Market size was valued at US$ 18.62 Billion in 2025 and is projected to...

The cardiovascular devices market is expanding as healthcare providers increasingly adopt advanced technologies to diagnose, monitor, and treat heart and blood vessel disorders. Cardiovascular devices play an essential role in modern healthcare, supporting procedures ranging from cardiac monitoring and diagnostic imaging to minimally invasive interventions and surgical treatments. Growing...

The global industry was valued at US$ 4.6 Bn in 2022 and is estimated to grow at a CAGR of 5.6% from 2023 to 2031, reaching US$ 7.6 Bn by the end of 2031. The hematology diagnostics market is experiencing steady growth as healthcare systems worldwide increasingly prioritize early disease detection, accurate diagnosis, and preventive healthcare. Hematology diagnostics plays a critical role in...

The Global Immunohistochemistry (IHC) Market is projected to grow from USD 4.4 billion in 2025 to approximately USD 7.6 billion by 2033, reflecting a CAGR of 7.4% during the forecast period. This growth is largely driven by advancements in diagnostic technologies, the increasing global burden of chronic diseases, and the expanding adoption of personalized medicine. For detailed market...

The global liquid biopsy market size stood at US$ 3.7 Bn in 2022 and is expected to increase at a CAGR of 8.8% from 2023 to 2031, reaching US$ 7.7 Bn by the end of 2031. The liquid biopsy market is rapidly transforming the global diagnostics and oncology landscape by offering minimally invasive solutions for cancer detection, monitoring, and treatment planning. Unlike traditional tissue...

The global molecular diagnostics market was valued at USD 18.8 billion in 2025. It is projected to reach USD 19.4 billion in 2026 and USD 25.6 billion by 2033, growing at a CAGR of 4.1% from 2026 to 2033, according to Grand View Research. North America led with a 44.1% revenue share in 2025. That growth is steady rather than explosive. Most of the value is concentrated in a few places:...

The rapid evolution of genomics research, precision medicine, and molecular diagnostics is creating significant opportunities for advanced sequencing technologies worldwide. The DNA library preparation, RNA sequencing market, and molecular biology reagents segments are becoming increasingly important as researchers and healthcare professionals seek accurate and efficient...

The rapid evolution of cancer molecular diagnostics, increasing adoption of molecular diagnostics in oncology, and growing demand for precision oncology diagnostics are transforming cancer detection and treatment worldwide. Molecular diagnostic technologies enable healthcare professionals to identify genetic mutations, biomarkers, and tumor-specific molecular...

  The global landscape for histocompatibility testing is undergoing a seismic shift as precision medicine becomes the standard of care. Recent HLA Typing Market analysis indicates that the integration of molecular diagnostics into routine clinical workflows has drastically improved the success rates of solid organ and hematopoietic stem cell transplants. By identifying specific alleles...

The Precision Diagnostics Market size was valued at US$ 66.86 billion in 2025 and is projected to reach US$ 166.34 billion by 2033, growing at a CAGR of 12.07% during 2026–2033. Market growth is best understood as the interaction between customer demand, operating economics, and supplier execution. The opportunity expands when buyers see measurable value, but commercialization still...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...

The AI in oncology market is entering a rapid expansion phase as healthcare providers, researchers, and pharmaceutical companies increasingly use artificial intelligence to improve cancer diagnostics, treatment planning, and research. The market was valued at USD 6.0 billion in 2025 and is projected to grow from USD 8.3 billion in 2026 to USD 38.9 billion by 2033, registering a CAGR of 24.8%...

The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...

Microfluidics Market: Transforming Precision Diagnostics, Drug Discovery, and Point-of-Care Healthcare Microfluidics Market Snapshot The Microfluidics Market is witnessing remarkable growth as miniaturized fluid-handling technologies revolutionize healthcare diagnostics, life sciences research, pharmaceutical development, and industrial applications. According to M2Square...

The proteomics market is entering a period of rapid expansion as healthcare and life sciences organizations increasingly use protein analysis to understand disease mechanisms, identify biomarkers, develop targeted therapies, and advance personalized medicine. The market was valued at USD 38.4 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 97.7 billion by 2033,...

The autoimmune disease diagnostics market is gaining momentum as the growing burden of autoimmune disorders increases demand for early, accurate, and efficient disease detection. The market was valued at USD 6.1 billion in 2025 and is estimated to reach USD 6.4 billion in 2026. It is projected to expand to USD 9.6 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033. The increasing...

The immunoassay market is entering a period of steady expansion as healthcare systems increasingly prioritize early disease detection, biomarker analysis, personalized medicine, and rapid diagnostic testing. The market was valued at USD 28.0 billion in 2025 and is estimated to reach USD 29.3 billion in 2026, before growing to USD 40.3 billion by 2033. It is projected to expand at a 4.6% CAGR...